an observational study found that DIMS alone slowed myopia by 57%, whereas combination therapy slowed progression by 70%

Current evidence supports the use of ortho-k and both 0.01% and 0.05% atropine as highly effective, synergistic approaches to myopia control.

The combined MiSight + 0.01% atropine group exhibited the lowest myopia progression, with 0.35 D in year 1 and 0.44 D in year